Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,190,000 shares, an increase of 201.5% from the December 31st total of 394,700 shares. Based on an average trading volume of 3,000,000 shares, the short-interest ratio is presently 0.4 days.

Analyst Upgrades and Downgrades

Several research firms have recently commented on AEMD. StockNews.com began coverage on Aethlon Medical in a research note on Monday. They issued a “sell” rating for the company. HC Wainwright restated a “buy” rating and issued a $7.00 price target on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Trading Up 19.0 %

NASDAQ AEMD opened at $0.74 on Thursday. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $1.88. The stock has a market cap of $10.35 million, a price-to-earnings ratio of -0.26 and a beta of 1.61. The company’s 50 day moving average is $0.56 and its two-hundred day moving average is $0.45.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.